Heart Failure with Preserved Ejection Fraction: Definition, Uses, and Clinical Overview

Heart Failure with Preserved Ejection Fraction Introduction (What it is)

Heart Failure with Preserved Ejection Fraction is a type of heart failure where the heart’s pumping strength (ejection fraction) is not reduced.
It usually means the heart has trouble relaxing and filling normally, so pressures rise even if the squeeze looks “normal” on imaging.
It is commonly discussed in cardiology clinics, hospital medicine, and echocardiography reports when evaluating shortness of breath, swelling, or exercise intolerance.
It is often shortened to HFpEF after the full term is introduced.

Why Heart Failure with Preserved Ejection Fraction used (Purpose / benefits)

Heart failure is a clinical syndrome, not a single test result. The term Heart Failure with Preserved Ejection Fraction is used to classify a person’s heart failure pattern when symptoms and signs of congestion (fluid buildup) occur despite a preserved left ventricular ejection fraction (LVEF), typically measured by echocardiography.

Using this definition serves several purposes:

• Clarifies the clinical problem being addressed. Many patients have breathlessness or edema for multiple reasons (heart, lung, kidney, anemia, deconditioning). Labeling Heart Failure with Preserved Ejection Fraction signals that heart-related filling pressure problems are suspected or confirmed.
• Guides diagnostic strategy. HFpEF often requires looking beyond “How strong is the squeeze?” and focusing on diastolic function, left atrial size, pulmonary pressures, and markers of congestion.
• Supports risk stratification and monitoring. Even with preserved ejection fraction, patients may have recurrent symptoms, hospitalizations, and reduced exercise capacity. A consistent diagnostic label helps clinicians track severity and response over time.
• Frames treatment goals. In HFpEF, goals often include symptom relief, control of contributing conditions (such as high blood pressure), management of volume status, and addressing rhythm problems like atrial fibrillation. The exact approach varies by clinician and case.
• Improves communication. The term creates a shared language among cardiologists, primary care clinicians, imaging specialists, and trainees when reviewing imaging, hemodynamics, and clinical notes.

Importantly, Heart Failure with Preserved Ejection Fraction describes a syndrome that can arise from several underlying mechanisms, so clinicians often pair it with the suspected driver (for example, hypertensive heart disease, obesity-related HFpEF, infiltrative cardiomyopathy, or valvular disease) when the evidence supports that.

Clinical context (When cardiologists or cardiovascular clinicians use it)

Common situations where Heart Failure with Preserved Ejection Fraction is considered include:

• Unexplained shortness of breath with exertion, especially when lung testing is not clearly abnormal
• Leg swelling, abdominal bloating, or weight gain with signs of fluid retention
• Recurrent hospital visits for “fluid overload” despite a reported normal or near-normal LVEF
• Older adults with long-standing hypertension, left ventricular thickening, or left atrial enlargement
• Patients with atrial fibrillation and symptoms that worsen with loss of coordinated atrial contraction
• People with obesity, diabetes, chronic kidney disease, or sleep-disordered breathing and progressive exercise intolerance
• Elevated natriuretic peptides (blood markers of cardiac wall stress) in the right clinical setting, recognizing that values can be lower in obesity and higher in kidney disease
• Evaluation of pulmonary hypertension where left-sided filling pressures are suspected to be contributing
• Differentiating cardiac vs non-cardiac causes of dyspnea using echocardiography, stress testing, cardiac MRI, or invasive hemodynamic testing when needed

Contraindications / when it’s NOT ideal

Heart Failure with Preserved Ejection Fraction is a clinical classification, not a medication or procedure, so “contraindications” mainly mean situations where the label is not appropriate, incomplete, or potentially misleading.

Situations where another diagnosis or approach may be better include:

• Reduced ejection fraction: If LVEF is clearly reduced, the condition is typically categorized differently (for example, heart failure with reduced ejection fraction).
• Primary valvular disease driving symptoms: Severe aortic stenosis or severe mitral regurgitation can cause heart failure symptoms even with preserved LVEF; the primary issue may be the valve.
• Constrictive pericarditis or significant pericardial disease: Filling problems arise from the pericardium rather than typical HFpEF physiology, and testing/management differs.
• High-output heart failure: Conditions like severe anemia, certain thyroid disorders, or arteriovenous shunts can cause heart failure symptoms with preserved LVEF but via a different mechanism.
• Non-cardiac causes of dyspnea predominate: Chronic lung disease, pulmonary embolism, deconditioning, or anxiety-related dyspnea can mimic HFpEF; careful evaluation is required.
• Measurement uncertainty: Ejection fraction and diastolic indices can be challenging to measure in poor echo windows, significant arrhythmia, or technically limited studies; additional imaging or repeat assessment may be needed.
• Borderline EF ranges: Patients near the lower end of “preserved” may be described differently depending on guideline definitions and clinician judgment (varies by clinician and case).

How it works (Mechanism / physiology)

Heart Failure with Preserved Ejection Fraction is commonly understood as a problem of filling and pressure, not primarily a problem of weak squeezing.

Mechanism and physiologic principle

• Ejection fraction (EF) is the percentage of blood pumped out of the left ventricle with each beat. A “preserved” EF means the proportion ejected is not reduced, but it does not guarantee normal overall heart performance.
• In HFpEF, the left ventricle often becomes stiffer or relaxes less effectively during diastole (the filling phase).
• When relaxation is impaired or stiffness is increased, the ventricle may need higher filling pressures to accept a normal amount of blood. Those higher pressures can transmit backward to the left atrium and lungs, contributing to congestion and shortness of breath.

Relevant cardiovascular anatomy and tissue

• Left ventricle (LV): Often shows concentric remodeling or hypertrophy (thickening) in some patients, though patterns vary.
• Left atrium (LA): May enlarge over time as it faces higher pressures, and enlargement can promote atrial fibrillation.
• Pulmonary veins and lung circulation: Elevated left-sided pressures can raise pulmonary pressures, leading to exertional breathlessness.
• Right ventricle (RV): Can be affected secondarily if pulmonary pressures become persistently elevated.
• Coronary microvasculature and myocardium: Some HFpEF phenotypes are associated with microvascular dysfunction, fibrosis, or infiltrative disease; these are evaluated selectively based on clinical context.

Time course and clinical interpretation

• HFpEF can be chronic (slowly progressive exercise intolerance) with acute decompensations (episodes of worsening congestion).
• Some contributors are potentially modifiable (blood pressure, volume overload, rhythm control, ischemia), while others may reflect longer-term structural changes (fibrosis, remodeling).
• A preserved EF can coexist with meaningful limitations in cardiac reserve during exercise, so clinicians often interpret HFpEF using symptoms, exam findings, imaging, biomarkers, and sometimes hemodynamics, rather than EF alone.

Heart Failure with Preserved Ejection Fraction Procedure overview (How it’s applied)

Heart Failure with Preserved Ejection Fraction is not a single procedure or one test. It is assessed and applied as a clinical diagnosis using a structured evaluation.

A typical high-level workflow is:

1. Evaluation / exam
   – Review symptoms (exertional dyspnea, fatigue, swelling, orthopnea) and triggers.
   – Physical exam for signs of congestion (jugular venous distension, lung crackles, edema), recognizing these may be absent between flare-ups.
   – Medication and comorbidity review (hypertension, diabetes, kidney disease, atrial fibrillation, lung disease, sleep-disordered breathing).

2. Preparation (initial testing plan)
   – Basic labs and biomarkers may be used to evaluate cardiac stress, anemia, kidney function, and contributing systemic illness.
   – ECG to assess rhythm, conduction, and prior infarction patterns.

3. Intervention / testing
   – Echocardiography to measure LVEF and assess diastolic parameters, left atrial size, ventricular wall thickness, valve disease, and estimated pulmonary pressures.
   – Additional tests when needed: stress testing (exercise or pharmacologic), ambulatory rhythm monitoring, cardiac MRI for tissue characterization, or coronary evaluation if ischemia is suspected.
   – In select cases, invasive hemodynamic assessment (right heart catheterization at rest and/or with exercise or fluid challenge) may be used to confirm elevated filling pressures when noninvasive data are inconclusive.

4. Immediate checks (interpretation and classification)
   – Determine whether symptoms/signs are consistent with heart failure and whether EF is preserved.
   – Assess for alternate primary explanations (lung disease, severe valve disease, pericardial disease, high-output states).

5. Follow-up (monitoring and reassessment)
   – Track symptom burden, volume status trends, rhythm changes, and repeat imaging or labs when clinically indicated.
   – Management plans are individualized and may evolve as comorbidities and cardiac structure change (varies by clinician and case).

Types / variations

Heart Failure with Preserved Ejection Fraction is increasingly understood as a heterogeneous syndrome with multiple phenotypes. Common ways clinicians describe variations include:

• Acute decompensated HFpEF vs chronic HFpEF
• Acute: sudden worsening congestion, often prompting urgent care or hospitalization.

• Chronic: longer-term limitations with intermittent exacerbations.

• Exercise-induced vs resting congestion

• Some patients have relatively normal pressures at rest but develop abnormal elevations during exertion, contributing to exertional dyspnea.

• Hypertension-associated or “stiff LV” phenotype

• Often includes concentric LV remodeling/hypertrophy and left atrial enlargement, with longstanding elevated afterload.

• Obesity- and metabolic-associated HFpEF

• Frequently overlaps with diabetes, sleep-disordered breathing, and systemic inflammation; natriuretic peptide levels may be less elevated than expected.

• Atrial fibrillation–associated HFpEF

• Symptoms can worsen due to loss of atrial contribution to filling, rapid rates, and irregular rhythm; AF may be both cause and consequence.

• Pulmonary hypertension / right heart involvement

• HFpEF may contribute to pulmonary venous hypertension, which can strain the right ventricle over time.

• Infiltrative or restrictive cardiomyopathy mimics within the preserved EF range

• Examples include cardiac amyloidosis or other restrictive processes that may present with preserved EF but distinct imaging and management considerations.

• Diagnostic frameworks and scoring approaches

• Some clinicians use structured algorithms or scores integrating echo findings, natriuretic peptides, and clinical factors to estimate likelihood when diagnosis is uncertain (exact method varies by clinician and case).

Pros and cons

Pros:

• Helps differentiate heart failure syndromes beyond “normal EF vs low EF”
• Emphasizes diastolic function, filling pressures, and congestion mechanisms
• Supports a structured approach to unexplained dyspnea and exercise intolerance
• Encourages assessment of comorbidities that commonly drive symptoms
• Improves communication across cardiology, imaging, and inpatient/outpatient teams
• Can guide selection of additional testing when the diagnosis is unclear

Cons:

• EF can be “preserved” while important dysfunction exists, so the term may feel counterintuitive to patients
• HFpEF is a broad category with multiple causes; a single label may oversimplify
• Noninvasive tests can be inconclusive, especially when symptoms occur mainly with exertion
• Natriuretic peptide levels can be influenced by body size, kidney function, and rhythm, complicating interpretation
• Symptoms overlap with lung disease, deconditioning, and anemia, increasing misclassification risk
• Management evidence and care pathways may be more individualized than for some other heart failure categories (varies by clinician and case)

Aftercare & longevity

Because Heart Failure with Preserved Ejection Fraction is typically a long-term condition with variable course, “aftercare” usually refers to ongoing monitoring and supportive cardiovascular care rather than recovery from a single intervention.

Factors that commonly affect outcomes over time include:

• Severity and frequency of congestion episodes and how quickly changes are recognized and evaluated
• Blood pressure control and vascular health, since chronic pressure load can worsen stiffness and remodeling
• Heart rhythm stability, especially the presence and burden of atrial fibrillation or other tachyarrhythmias
• Kidney function, which influences volume balance and medication options
• Cardiometabolic comorbidities (obesity, diabetes, sleep-disordered breathing), which can amplify symptoms and inflammation
• Physical conditioning and functional capacity, often addressed through supervised exercise or rehabilitation programs when offered and appropriate (availability and approach vary by clinician and case)
• Follow-up consistency and reassessment when symptoms change, including repeat imaging or testing when clinically indicated
• Underlying drivers (for example, valve disease or infiltrative cardiomyopathy) when present, since prognosis and management differ by cause

HFpEF symptoms can fluctuate. Many patients experience periods of stability with intermittent worsening, particularly during intercurrent illness, dietary changes affecting fluid balance, medication changes, or rhythm disturbances.

Alternatives / comparisons

Heart Failure with Preserved Ejection Fraction is one category within a broader set of diagnoses that can cause similar symptoms. Comparisons are often made to:

• Heart failure with reduced ejection fraction (HFrEF)
• Core distinction: reduced vs preserved LVEF.

• Diagnostic evaluation overlaps (symptoms, congestion, imaging), but treatment frameworks and clinical trial evidence differ in important ways.

• Heart failure with mildly reduced ejection fraction (HFmrEF)

• An intermediate EF range in some guidelines; may share features of both HFpEF and HFrEF. Classification can vary by guideline and clinician.

• Non-cardiac causes of dyspnea (alternative diagnoses)

• Chronic obstructive pulmonary disease, asthma, interstitial lung disease, pulmonary embolism, anemia, thyroid disease, and deconditioning can mimic HFpEF symptoms.

• Clinicians compare findings from physical exam, lung testing, imaging, biomarkers, and response patterns over time to refine the diagnosis.

• Valvular heart disease

• Severe valve lesions can cause heart failure symptoms with preserved EF but may call for valve-focused evaluation and potential intervention.

• Pericardial disease

• Constrictive pericarditis can resemble HFpEF; distinguishing features may come from imaging and invasive hemodynamics.

• Testing approaches: noninvasive vs invasive

• Echocardiography is often first-line, while cardiac MRI offers additional structural and tissue detail in selected cases.
• Right heart catheterization is more invasive but can directly measure pressures when uncertainty persists, especially with exertional symptoms.

Heart Failure with Preserved Ejection Fraction Common questions (FAQ)

Q: Does Heart Failure with Preserved Ejection Fraction mean my heart is “normal”?
No. A preserved ejection fraction means the percentage pumped out with each beat is not reduced, but it does not guarantee normal relaxation, filling pressures, valve function, or exercise response. HFpEF indicates heart failure physiology can still be present even when pumping strength looks preserved.

Q: Is Heart Failure with Preserved Ejection Fraction painful?
The condition itself is not typically described as painful. People more often report shortness of breath, fatigue, chest tightness, or swelling. If chest pain is present, clinicians usually evaluate for other causes such as coronary disease or non-cardiac sources (varies by clinician and case).

Q: How is Heart Failure with Preserved Ejection Fraction diagnosed?
Diagnosis usually combines symptoms, exam findings, echocardiography, and supportive tests like ECG and labs. When the picture is unclear, clinicians may use stress testing, cardiac MRI, or invasive pressure measurements to confirm whether filling pressures are elevated.

Q: Will I need to be hospitalized?
Some patients are diagnosed in clinic, while others first present during an episode of worsening congestion that requires emergency care or hospitalization. Hospitalization risk depends on symptom severity, comorbidities, and how abruptly symptoms worsen (varies by clinician and case).

Q: What tests are commonly involved, and do they have risks?
Echocardiography and ECG are noninvasive and widely used. Blood tests are generally low risk aside from routine blood draw risks. More advanced testing—like CT scans with contrast, stress testing, or cardiac catheterization—has additional risks and is used selectively based on the clinical question (varies by clinician and case).

Q: How long do the results “last,” and can the diagnosis change?
HFpEF is often a chronic diagnosis, but the severity can fluctuate and the underlying drivers may evolve. Ejection fraction can also change over time, especially after major events like heart attacks, sustained arrhythmias, or progression of valve disease, so clinicians may reassess the category when new data emerge.

Q: Are there activity restrictions with Heart Failure with Preserved Ejection Fraction?
Activity guidance is individualized and depends on symptoms, rhythm stability, blood pressure, and comorbidities. Many patients are evaluated for safe levels of activity, and some are referred to supervised rehabilitation or structured exercise programs when available and appropriate (varies by clinician and case).

Q: What is the cost range for evaluation and care?
Costs vary widely based on location, insurance coverage, and which tests are needed. A basic clinic evaluation and echocardiogram is usually different in cost than advanced imaging, stress testing, or invasive hemodynamic assessment. The setting (outpatient vs inpatient) also strongly affects cost.

Q: Is Heart Failure with Preserved Ejection Fraction considered “safe” or “less serious” than other heart failure types?
It is not accurate to consider HFpEF automatically mild simply because EF is preserved. Some people have stable symptoms for long periods, while others have recurrent exacerbations and significant limitations. Risk depends on congestion burden, comorbidities, rhythm issues, kidney function, and underlying heart disease (varies by clinician and case).

Q: What does “preserved ejection fraction” usually mean on an echocardiogram?
It generally means the left ventricle’s pumping percentage is within the range considered normal by the interpreting lab. Different labs and guidelines may use slightly different thresholds, and EF measurement has some variability. Clinicians interpret EF alongside diastolic measures, chamber sizes, valve findings, and symptoms.